01 10Genotropin
02 3Humatrope
03 3Norditropin
04 4Nutropin
05 5NutropinAq
Main Therapeutic Indication : Rare Disorders
Currency : USD
2019 Revenue in Millions : 498
2018 Revenue in Millions : 558
Growth (%) : -11
Main Therapeutic Indication : Hormonal Disorders
Currency : USD
2020 Revenue in Millions : 45
2019 Revenue in Millions : 51
Growth (%) : -12
Main Therapeutic Indication : Rare Disorders
Currency : USD
2020 Revenue in Millions : 427
2019 Revenue in Millions : 498
Growth (%) : -14
Main Therapeutic Indication : Rare Disorders
Currency : USD
2021 Revenue in Millions : 389
2020 Revenue in Millions : 427
Growth (%) : -9
Main Therapeutic Indication : Hormonal Disorders
Currency : USD
2021 Revenue in Millions : 35
2020 Revenue in Millions : 44
Growth (%) : -12
Main Therapeutic Indication : Rare Diseases
Currency : USD
2022 Revenue in Millions : 29
2021 Revenue in Millions : 35
Growth (%) : -17
Main Therapeutic Indication : Rare Diseases
Currency : USD
2023 Revenue in Millions : 20
2022 Revenue in Millions : 29
Growth (%) : -31
Main Therapeutic Indication : Rare Diseases
Currency : USD
2022 Revenue in Millions : 360
2021 Revenue in Millions : 389
Growth (%) : -7
Main Therapeutic Indication : Rare Diseases
Currency : USD
2023 Revenue in Millions : 539
2022 Revenue in Millions : 360
Growth (%) : 50
Main Therapeutic Indication : Harmonal Disorders
Currency : USD
2015 Revenue in Millions : 325
2014 Revenue in Millions : 312
Growth (%) : -4%
LOOKING FOR A SUPPLIER?